To better prepare for the next pandemic, a new paper in Australia suggests expanding vaccine production options, diversifying virus knowledge, and creating national data standards.

Strengthening Australia’s Pandemic Preparedness, a new report from the CSIRO, an Australian agency evaluated a number of scientific and technological fields. It was created after extensive system-wide consultation and input from more than 140 experts from business, academia, and government. Over 13,000 Australians have already lost their lives as a result of the COVID pandemic, resulting in reduced Australia’s expected economic output by $144 billion.

The research gives Australia credit for keeping COVID-19 infections lower than in other nations due to travel restrictions and quarantine, but claims that increased and centrally coordinated investment in science and technology can help the country better prepare for the next pandemic.

According to the paper, most viruses with pandemic potential have little worldwide understanding, making it challenging to respond quickly with medical countermeasures. It states that Australia would benefit from concentrating its preclinical efforts on virus families that pose a high risk of human pandemics given its limited resources.

Additionally, it suggests collaborating with international networks during preclinical studies, enhancing research capacities in animal models and other models, and bridging the gaps between science, business, and the healthcare system. As other nations limit their use to only specific uses due to moral considerations and public pressure, the research states that there is governmental reluctance to increase non-human primate capabilities.

The report also suggests broadening onshore production of various vaccine kinds and increasing contract manufacturing and development capabilities to assist vaccine trials in terms of immunisation as a defence against pandemics. Because of high input costs and a relatively small population to enable trial patient enrolments, fewer vaccine concepts undergo Phase II and III clinical trials in Australia, which results in the loss of intellectual property (IP) value.

Among the recommendations were to conduct early antiviral development studies and to increase research on medicines repurposing. The paper also suggests expanding the workforce in genetic epidemiology and related sectors, as well as creating a national genomic analytic authority and platform.

According to the research, Australia’s genomic response early in the COVID-19 pandemic was one of the finest globally, primarily facilitated by the initial low levels of cases. Because the genomic systems were unable to keep up with the rise in cases, Australia was not able to maintain this rate of testing.

Creating national pandemic data standards, enhancing the ability to combine health data with unrelated data, and creating analytics that can exchange and analyse data on a national scale are the final recommendations. Based on the report and recommendation of CSIRO, the appearance of widespread viral outbreaks is inevitable, and pandemics will continue to have a substantial direct and indirect influence on Australia.

The opportunity to improve Australia’s capacity to lessen the effects of upcoming pandemics is provided by the present worldwide emphasis on and investments in pandemic preparedness.

An extensive worldwide study supported by the National Institutes of Health found a modest increase in the length of a woman’s menstrual cycle after receiving the COVID-19 vaccine, which delayed the onset of bleeding by a few hours.

The NIH’s child health and human development institute’s director, Dr. Diana Bianchi, stated that the alterations brought on by vaccination seem minor, transient, and within the usual range. According to the health service, the extended menstrual cycle, which is generally approximately a month long, did not exactly raise the number of days of bleeding.

According to the NIH, a change in menstrual cycle duration of eight days or less is seen as falling within the normal range of variation. The study’s results showed that participants’ menstrual cycles lengthened on average by.71 days, or even less than 24 hours, after the first vaccine dosage and by a little over half a day after the second dose. When both vaccine doses were given to a woman at once, her cycle lengthened by 3.91 days.

But more than 1,300 women, or 6.2% of the study’s vaccinated subjects and 5% of the unvaccinated, experienced a period lengthening of eight days or more. A larger delay in the start of periods was more likely to be observed among younger women who experienced a longer cycle prior to immunisation.

For women who got one dosage per menstrual cycle and within roughly 20 hours for those who got both doses in a single period, cycle duration had mostly reverted to normal following the immunisation series. The study included around 20,000 participants from Canada, the U.K., the U.S., Europe, and other countries. Moderna, Pfizer-BioNTech, Johnson & Johnson, AstraZeneca, Sputnik, Covishield, Covaxin, Sinopharm, and Sinovac were among the nine vaccinations administered to participants.

The length of the menstrual cycle did not change differently between vaccinations.

The researchers used information from the Natural Cycles fertility tracking app. Women gave the app data about their body temperature and menstrual length. Users of the app have the choice to opt-out of their personally identifying information being used to identify them when they contribute their data for research.

The study presented this week validated the preliminary findings that had been published in January, revealing a connection between COVID immunisation and lengthened menstrual cycles. Five research organisations received $1.67 million from the NIH to study the problem.

Employers, including those from the healthcare industry, should put forth all possible efforts to ensure employee safety. Unfortunately, avoiding workplace accidents completely is impossible, even with the best safety protocols and training. The aftermath of workplace accidents, be it injuries or death, have long-lasting effects on the affected party and other employees.

The accident can traumatize or scare the injured worker. They also incur medical expenses and lose income, though these can be mitigated with injury lawyers, which you can learn more about here. Fortunately, businesses can avoid these costs and the possibility of a lawsuit by taking worker’s compensation insurance. Below, we’ve listed a few things to be on the lookout for after an accident:

The Aftermath of Workplace Accidents

The period after the incident is incredibly scary, stressful, and costly for the affected employee and their families. The injured worker will struggle with medical expenses, lost wages, recovery time, and emotional trauma. They should also deal with the complications of obtaining insurance compensation through personal injury lawsuits, worker’s compensation, or any other insurance cover available.

Increasing expenses and the inability to resume work during recovery take a serious financial toll on the affected employee. While the employee can benefit from worker’s compensation if the healthcare institution subscribes to worker’s compensation, most insurance companies strive to pay the bare minimum, typically compensating only for the injury and lost time. This leaves the affected workers in difficult financial positions, especially if they can’t resume work immediately.

The Iceberg Effect

It is typical for employers to start investigations into the cause of the accident immediately after the incident. Most employers even form commissions of inquiry to identify the root cause, impact, and preventable costs associated with the incident. Unfortunately, most people think that workplace incidents and associated costs can be recovered through insurance.

Unfortunately, this isn’t always the case. The costs associated with ill-health, life-long injuries and death caused by workplace injuries are called the “iceberg effect.” While visible costs can be recovered, there are hidden costs that can’t be recovered, even through insurance. According to the Health and Safety Executive, these costs are ten times more than insured costs. The hidden costs associated with workplace accidents include:

• Loss of production time
• Investigation time
• Extra wages, temporary labor, and overtime pay to cover for the missing employees
• Legal costs in case of lawsuits
• Prosecution time
• Sick pay
• Damaged reputation

Since these costs aren’t covered by insurance, it takes up a significant amount of the employer’s revenue and profits.

Psychological Effects

Workplace accidents, especially in the healthcare environment, have significant psychological effects, including depression and anxiety, further reducing productivity. A study found that more than half of previously injured employees have anxiety while a quarter have benign depressive symptoms. These effects extend beyond the workplace, often affecting individual hobbies and families.

Endnote

Serious workplace accidents affect employees, regardless of whether they shared an office, had close relationships with the affected employee, or witnessed the accident. Besides the direct effects on the injured employee, accidents also affect the morale of your entire workforce. Healthcare institutions should adhere to various safety protocols that ensure maximum employee safety.